VERU INC. Net Cash Provided by (Used in) Investing Activities, Continuing Operations
VERU INC. (VERU) reported Net Cash Provided by (Used in) Investing Activities, Continuing Operations of -$90.37 thousand for the 12-month period ending 2017-09-30, per its 10-K filed 2018-01-02.
Discontinued › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations · last filed 2018-01-02
- VERU INC. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2017-09-30 was $29.05K.
- VERU INC. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2017-06-30 was -$35.93K.
- VERU INC. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2017-03-31 was -$17.87K, a 8902.46% decline year-over-year.
- VERU INC. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2016-12-31 was -$65.62K.
- VERU INC. net cash provided by (used in) investing activities, continuing operations for fiscal 2017 was -$90.37K.
- VERU INC. net cash provided by (used in) investing activities, continuing operations for fiscal 2016 was -$6.37K.
- VERU INC. net cash provided by (used in) investing activities, continuing operations for fiscal 2015 was -$135.42K.
- VERU INC. net cash provided by (used in) investing activities, continuing operations for fiscal 2014 was -$97.31K.
| Period end | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 3 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 6 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 9 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 12 month |
|---|---|---|---|---|
| 2017-09-30 | $29.05K derived: 10-K 12 month − 10-Q 9 month · filed 2018-01-02 | -$6.88K derived: sum of 2 quarters · filed 2018-01-02 | -$24.75K derived: sum of 3 quarters · filed 2018-01-02 | -$90.37K 10-K · filed 2018-01-02 |
| 2017-06-30 | -$35.93K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-08-09 | -$53.80K derived: sum of 2 quarters · filed 2017-08-09 | -$119.42K 10-Q · filed 2017-08-09 | -$122.37K derived: sum of 4 quarters · filed 2018-01-02 |
| 2017-03-31 | -$17.87K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-05-10 | -$83.49K 10-Q · filed 2017-05-10 | -$86.44K derived: sum of 3 quarters · filed 2018-01-02 | -$87.13K derived: sum of 4 quarters · filed 2018-01-02 |
| 2016-12-31 | -$65.62K 10-Q · filed 2017-02-09 | -$68.57K derived: sum of 2 quarters · filed 2018-01-02 | -$69.26K derived: sum of 3 quarters · filed 2018-01-02 | -$69.06K derived: sum of 4 quarters · filed 2018-01-02 |
| 2016-09-30 | -$2.95K derived: 10-K 12 month − 10-Q 9 month · filed 2018-01-02 | -$3.63K derived: sum of 2 quarters · filed 2018-01-02 | -$3.43K derived: sum of 3 quarters · filed 2018-01-02 | -$6.37K 10-K · filed 2018-01-02 |
| 2016-06-30 | -$686.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-08-09 | -$483.00 derived: sum of 2 quarters · filed 2017-08-09 | -$3.42K 10-Q · filed 2017-08-09 | -$11.26K derived: sum of 4 quarters · filed 2018-01-02 |
| 2016-03-31 | $203.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2017-05-10 | -$2.74K 10-Q · filed 2017-05-10 | -$10.57K derived: sum of 3 quarters · filed 2018-01-02 | -$111.12K derived: sum of 4 quarters · filed 2018-01-02 |
| 2015-12-31 | -$2.94K 10-Q · filed 2017-02-09 | -$10.78K derived: sum of 2 quarters · filed 2018-01-02 | -$111.33K derived: sum of 3 quarters · filed 2018-01-02 | -$136.08K derived: sum of 4 quarters · filed 2018-01-02 |
| 2015-09-30 | -$7.84K derived: 10-K 12 month − 10-Q 9 month · filed 2018-01-02 | -$108.38K derived: sum of 2 quarters · filed 2018-01-02 | -$133.14K derived: sum of 3 quarters · filed 2018-01-02 | -$135.42K 10-K · filed 2018-01-02 |
| 2015-06-30 | -$100.55K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-07-28 | -$125.31K derived: sum of 2 quarters · filed 2016-07-28 | -$127.59K 10-Q · filed 2016-07-28 | -$138.02K derived: sum of 4 quarters · filed 2016-12-12 |
| 2015-03-31 | -$24.76K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-04-28 | -$27.04K 10-Q · filed 2016-04-28 | -$37.48K derived: sum of 3 quarters · filed 2016-12-12 | -$40.36K derived: sum of 4 quarters · filed 2016-12-12 |
| 2014-12-31 | -$2.28K 10-Q · filed 2016-02-02 | -$12.72K derived: sum of 2 quarters · filed 2016-12-12 | -$15.60K derived: sum of 3 quarters · filed 2016-12-12 | -$17.69K derived: sum of 4 quarters · filed 2016-12-12 |
| 2014-09-30 | -$10.44K derived: 10-K 12 month − 10-Q 9 month · filed 2016-12-12 | -$13.32K derived: sum of 2 quarters · filed 2016-12-12 | -$15.41K derived: sum of 3 quarters · filed 2016-12-12 | -$97.31K 10-K · filed 2016-12-12 |
| 2014-06-30 | -$2.88K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-07-30 | -$4.97K derived: sum of 2 quarters · filed 2015-07-30 | -$86.88K 10-Q · filed 2015-07-30 | -$99.65K derived: sum of 4 quarters · filed 2015-12-02 |
| 2014-03-31 | -$2.09K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-04-30 | -$83.99K 10-Q · filed 2015-04-30 | -$96.76K derived: sum of 3 quarters · filed 2015-12-02 | |
| 2013-12-31 | -$81.90K 10-Q · filed 2015-02-03 | -$94.67K derived: sum of 2 quarters · filed 2015-12-02 | ||
| 2013-09-30 | -$12.77K derived: 10-K 12 month − 10-Q 9 month · filed 2015-12-02 | -$302.20K 10-K · filed 2015-12-02 | ||
| 2013-06-30 | -$289.43K 10-Q · filed 2014-07-31 | |||
| 2012-09-30 | -$654.18K 10-K · filed 2014-12-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |